Tubulin beta — Drug Target
All drugs that target Tubulin beta — marketed and clinical-stage. Includes 2 drug classes acting on this target.
Drug classes
CD30-directed Immunoconjugate [EPC] · Microtubule Inhibitor
Marketed (3)
- Adcetris · Pfizer · CD30-directed Immunoconjugate [EPC] · Oncology
Adcetris works by binding to cancer cells that express CD30 and delivering a toxic payload to kill the cells. - Halaven · Eisai · Microtubule Inhibitor · Oncology
Halaven works by binding to tubulin beta, disrupting microtubule dynamics and leading to cell death. - Jevtana Kit · Accord Hlthcare · Microtubule Inhibitor · Oncology
Cabazitaxel works by binding to tubulin beta, disrupting microtubule formation and preventing cancer cell division.